Nanoparticles for gene delivery: Formulation characteristics

Nanoparticulate Drug Delivery Systems

Volumn , Issue , 2007, Pages 291-303

  Vasir, Jaspreet K ^a   Labhasetwar, Vinod ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85132515304     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (42)

1. Li Z, Dullmann J, Schiedlmeier B, et al. Murine leukemia induced by retroviral gene marking. Science 2002; 296(5567):497.
2. Prabha S, Labhasetwar V. Critical determinants in PLGA/PLA nanoparticle-mediated gene expression. Pharm Res 2004; 21(2):354-364.
3. Cohen H, Levy RJ, Gao J, et al. Sustained delivery and expression of DNA encapsulated in polymeric nanoparticles. Gene Ther 2000; 7(22):1896-l905.
4. Ribeiro S, Hussain N, Florence AT. Release of DNA from dendriplexes encapsulated in PLGA nanoparticles. Int J Pharm 2005; 298(2):354-360.
5. Csaba N, Caamano P, Sanchez A, Dominguez F, Alonso MJ. PLGA:poloxamer and PLGA: poloxamine blend nanoparticles: new carriers for gene delivery. Biomacromolecules 2005; 6(1):271-278.
6. Maruyama A, Ishihara T, Kim JS, Kim SW, Akaike T. Nanoparticle DNA carrier with poly(L-lysine) grafted polysaccharide copolymer and poly(D,L-lactic acid). Bioconjug Chem 1997; 8(5):735-742.
7. Prabha S, Zhou WZ, Panyam J, Labhasetwar V. Size-dependency of nanoparticle-mediated gene transfection: studies with fractionated nanoparticles. Int J Pharm (2002); 244(1-2):105-115.
8. Kuo JH, Jan MS, Sung KC. Evaluation of the stability of polymer-based plasmid DNA delivery systems after ultrasound exposure. Int J Pharm 2003; 257(1-2):75-84.
9. Lengsfeld CS, Anchordoquy TJ. Shear-induced degradation of plasmid DNA. J Pharm Sci 2002; 91(7):1581-1589.
10. Middaugh CR, Evans RK, Montgomery DL, Casimiro DR. Analysis of plasmid DNA from a pharmaceutical perspective. J Pharm Sci 1998; 87(2):130-146.
11. Labhasetwar V, Bonadio J, Goldstein S, Levy RJ. Gene transfection using biodegradable nanospheres: results in tissue culture and a rat osteotomy model. Colloid Surf B 1999; 16:281-290.
12. Ando S, Putnam D, Pack DW, Langer R. PLGA microspheres containing plasmid DNA: preservation of supercoiled DNA via cryopreparation and carbohydrate stabilization. J Pharm Sci 1999; 88(1):126-130.
13. Oster CG, Wittmar M, Unger F, et al. Design of amine-modified graft polyesters for effective gene delivery using DNA-loaded nanoparticles. Pharm Res 2004; 21(6):927-931.
14. Murakami H, Kobayashi M, Takeuchi H, Kawashima Y. Preparation of poly(D,L-lactide-co-glycolide) nanoparticles by modified spontaneous emulsification solvent diffusion method. Int J Pharm 1999; 187(2):143-152.
15. Sahoo SK, Panyam J, Prabha S, Labhasetwar V. Residual polyvinyl alcohol associated with poly (D,L-lactide-co-glycolide) nanoparticles affects their physical properties and cellular uptake. J Control Release 2002; 82(1):105-114.
16. Prabha S, Labhasetwar V. Nanoparticle-mediated wild-type p53 gene delivery results in sustained antiproliferative activity in breast cancer cells. Mol Pharm 2004; 1(3):211-219.
17. Fu K, Pack DW, Klibanov AM, Langer R. Visual evidence of acidic environment within degrading poly(lactic-co-glycolic acid) (PLGA) microspheres. Pharm Res 2000; 17(1):100-106.
18. Tobio M, Nolley J, Guo Y, Mciver J, Alonso MJ. A novel system based on a poloxamer/ PLGA blend as a tetanus toxoid delivery vehicle. Pharm Res 1999; 16(5):682-688.
19. Ravi Kumar MN, Bakowsky U, Lehr CM. Preparation and characterization of cationic PLGA nanospheres as DNA carriers. Biomaterials 2004; 25(10):1771-1777.
20. Kim IS, Lee SK, Park YM, et al. Physicochemical characterization of poly(L-lactic acid) and poly(D,L-lactide-co-glycolide) nanoparticles with polyethylenimine as gene delivery carrier. Int J Pharm 2005; 298(1):255-262.
21. Redhead HM, Davis SS, Illum L. Drug delivery in poly(lactide-co-glycolide) nano-particles surface modified with poloxamer 407 and poloxamine 908: in vitro characterisation and in vivo evaluation. J Control Release 2001; 70(3):353-363.
22. Otsuka H, Nagasaki Y, Kataoka K. PEGylated nanoparticles for biological and pharmaceutical applications. Adv Drug Deliv Rev 2003; 55(3):403-419.
23. Benns JM, Kim SW. Tailoring new gene delivery designs for specific targets. J Drug Target 2000; 8(1):1-12.
24. Neal JC, Stolnik S, Schacht E, et al. In vitro displacement by rat serum of adsorbed radiolabeled poloxamer and poloxamine copolymers from model and biodegradable nano-spheres. J Pharm Sci 1998; 87(10):1242-1248.
25. Stolnik S, Dunn SE, Garnett MC, et al. Surface modification of poly(lactide-co-glycolide) nanospheres by biodegradable poly(lactide)-poly(ethylene glycol) copolymers. Pharm Res 1994; 11(12):1800-1808.
26. Hawley AE, Illum L, Davis SS. Preparation of biodegradable, surface engineered PLGA nanospheres with enhanced lymphatic drainage and lymph node uptake. Pharm Res 1997; 14(5):657-661.
27. Perez C, Sanchez A, Putnam D, et al. Poly(lactic acid)-poly(ethylene glycol) nanoparticles as new carriers for the delivery of plasmid DNA. J Control Release 2001; 75(1-2): 211-224.
28. Lee KY, Kwon IC, Kim YH, Jo WH, Jeong SY. Preparation of chitosan self-aggregates as a gene delivery system. J Control Release 1998; 51(2-3):213-220.
29. Mao HQ, Roy K, Troung-Le VL, et al. Chitosan-DNA nanoparticles as gene carriers: synthesis, characterization and transfection efficiency. J Control Release 2001; 70(3): 399-421.
30. Mumper RJ, Wang J, Claspell JM, Rolland AR Novel polymeric condensing carriers for gene delivery. Proc Int Symp Control Rel Bioact Mater 1995; 22:178-179.
31. Bernkop-Schnurch A, Krajicek ME. Mucoadhesive polymers as platforms for peroral peptide delivery and absorption: synthesis and evaluation of different chitosan-EDTA conjugates. J Control Release 1998; 50(1-3):215-223.
32. Lynn DM, Langer R. Degradable poly(beta-amino esters): synthesis, characterization, and self-assembly with plasmid DNA. J Am Chem Soc 2000; 122:10761-10768.
33. Lynn DM, Amiji MM, Langer R. pH-responsive polymer microspheres: rapid release of encapsulated material within the range of intracellular pH. Angew Chem Int Ed Engl 2001; 40(9):1707-1710.
34. Couvreur P, Kante B, Roland M, et al. Polycyanoacrylate nanocapsules as potential lyso-somotropic carriers: preparation, morphological and sorptive properties. J Pharm Pharmacol 1979; 31(5):331-332.
35. Chavany C, Le Doan T, Couvreur P, Puisieux F, Helene C. Polyalkylcyanoacrylate nanoparticles as polymeric carriers for antisense oligonucleotides. Pharm Res 1992; 9(4): 441-449.
36. Godard G, Boutorine AS, Saison-Behmoaras E, Helene C. Antisense effects of cholesterol-oligodeoxynucleotide conjugates associated with poly(alkylcyanoacrylate) nanoparticles. Eur J Biochem 1995; 232(2):404-410.
37. Lenaerts V, Nagelkerke JF, Van Berkel TJ, et al. In vivo uptake of polyisobutyl cyanoacrylate nanoparticles by rat liver Kupffer, endothelial, and parenchymal cells. J Pharm Sci 1984; 73(7):980-982.
38. Scherer F, Anton M, Schillinger U, et al. Magnetofection: enhancing and targeting gene delivery by magnetic force in vitro and in vivo. Gene Ther 2002; 9(2):102-109.
39. Morishita N, Nakagami H, Morishita R, et al. Magnetic nanoparticles with surface modification enhanced gene delivery of HVJ-E vector. Biochem Biophys Res Commun 2005; 334(4):1121-1126.
40. Munkonge FM, Dean DA, Hillery E, Griesenbach U, Alton EW. Emerging significance of plasmid DNA nuclear import in gene therapy. Adv Drug Deliv Rev 2003; 55(6):749-760.
41. Park YJ, Liang JF, Ko KS, Kim SW, Yang VC. Low molecular weight protamine as an efficient and nontoxic gene carrier: in vitro study. J Gene Med 2003; 5(8):700-711.
42. Labhasetwar V. Nanotechnology for drug and gene therapy: the importance of understanding molecular mechanisms of delivery. Curr Opin Biotechnol 2005; 16(6):674-680.